Philips, LindaCare partner up on remote cardiac monitoring, informatics

Philips building
Philips is also debuting the latest release of its EPIQ CVx heart ultrasound platform with automated applications for 2D assessments and 3D scans of right ventricle volume and ejection fraction. (Philips)

Philips has announced plans to combine LindaCare’s cloud-based platform, designed to help remotely monitor patients with electronic cardiac implants, with its IntelliSpace Cardiovascular informatics program.

“Monitoring and follow-up of cardiac arrhythmia patients with [cardiac implantable electronic devices] can be often complex, with data trapped in different silos that need to be reviewed individually,” Philips’ business leader for enterprise diagnostic informatics, Calum Cunningham, said in a statement ahead of the European Society of Cardiology (ESC) Congress in Paris.

“LindaCare’s innovative OnePulse solution consolidates this data, and by incorporating OnePulse into our IntelliSpace Cardiovascular platform, caregivers can see this additional information as part of the broader cardiovascular history of each patient, allowing them to make the most appropriate treatment decisions for each patient,” Cunningham added.

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Philips’ web-based workflow platform is designed to collate imaging results and other data across hospitals for cardiology departments and provide them to different applications. The addition of LindaCare’s system will help clinicians track patients’ recovery outside the building as well as provide for alerts and triaging.

"This step is a significant achievement in our partnership with Philips creating value for both companies, as it accelerates our market access and brings our innovation to Philips' customers," said LindaCare founder and CEO Shahram Sharif. Philips previously backed LindaCare in its January 2018 series B round through its Health Technology Ventures arm, giving the medtech giant a minority stake in the company as a strategic partner.

Separately, Philips is also developing a software module that will automate reports for patients with cardiac implants during hospital visits. Both new interfaces are expected to be available later this year, the company said.

RELATED: To Philips, the future means selling more than a better MRI machine

Elsewhere at the ESC Congress, Philips is debuting the latest release of its EPIQ CVx heart ultrasound platform with automated applications for 2D assessments as well as 3D scans of right ventricle volume and ejection fraction. Philips says the automation helps limit variability between scans when diagnosing atrial fibrillation, arrhythmia and other heart conditions and that it can reduce the number of touches of the system during exams by about one-fifth.

Suggested Articles

A COVID-19 antibody diagnostic developed through a joint venture between Mount Sinai Health System and RenalytixAI has been authorized by the FDA.

Researchers at Northwestern University have trained an AI algorithm to automatically detect the signs of COVID-19 on a basic X-ray of the lungs.

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.